{
  "therapeutic_antibodies": [
    {
      "name": "Adalimumab",
      "sequence": {
        "heavy_chain": "EVQLVESGGGLVQPGGSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSAITWNSGHIDYADSVEGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAKVSYLSTASSLDYWGQGTLVTVSS",
        "light_chain": "DIQMTQSPSSLSASVGDRVTITCRASQGIRNYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCQRYNRAPYTFGQGTKVEIK"
      },
      "target": "TNF-alpha",
      "approved": true,
      "year": 2002,
      "company": "AbbVie",
      "disease_areas": ["Rheumatoid Arthritis", "Psoriasis", "Crohn's Disease"],
      "antibody_type": "Human",
      "isotype": "IgG1",
      "cdr_regions": {
        "heavy": {
          "cdr1": "DDYAMH",
          "cdr2": "AITWNSGHIDYAD",
          "cdr3": "AKVSYLSTASSLD"
        },
        "light": {
          "cdr1": "RASQGIRNYLA",
          "cdr2": "AASTLQS",
          "cdr3": "QRYNRAPYT"
        }
      }
    },
    {
      "name": "Trastuzumab",
      "sequence": {
        "heavy_chain": "EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEWVARIYPTNGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDYWGQGTLVTVSS",
        "light_chain": "DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIK"
      },
      "target": "HER2",
      "approved": true,
      "year": 1998,
      "company": "Genentech/Roche",
      "disease_areas": ["Breast Cancer", "Gastric Cancer"],
      "antibody_type": "Humanized",
      "isotype": "IgG1",
      "cdr_regions": {
        "heavy": {
          "cdr1": "GFNIKDTYIH",
          "cdr2": "RIYPTNGYTRYA",
          "cdr3": "SRWGGDGFYAMDY"
        },
        "light": {
          "cdr1": "RASQDVNTAVA",
          "cdr2": "SASFLYS",
          "cdr3": "QQHYTTPPT"
        }
      }
    },
    {
      "name": "Pembrolizumab",
      "sequence": {
        "heavy_chain": "EVQLVESGGGLVQPGGSLRLSCAASGFTFSDSWIHWVRQAPGKGLEWVAWISPYGGSTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCAREHPWFCEALSCLYFDYWGQGTLVTVSS",
        "light_chain": "EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQRSNWPPTFGQGTKVEIK"
      },
      "target": "PD-1",
      "approved": true,
      "year": 2014,
      "company": "Merck",
      "disease_areas": ["Melanoma", "Lung Cancer", "Head and Neck Cancer"],
      "antibody_type": "Humanized",
      "isotype": "IgG4",
      "cdr_regions": {
        "heavy": {
          "cdr1": "GFTFSDSWIH",
          "cdr2": "WISPYGGSTYYA",
          "cdr3": "AREHPWFCEALSCLYFD"
        },
        "light": {
          "cdr1": "RASQSVSSYLA",
          "cdr2": "DASNRAT",
          "cdr3": "QQRSNWPPT"
        }
      }
    },
    {
      "name": "Rituximab",
      "sequence": {
        "heavy_chain": "QVQLQQPGAELVKPGASVKMSCKASGYTFTSYNMHWVKQTPGRGLEWIGAIYPGNGDTSYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYCARSTYYGGDWYFNVWGAGTTVTVSA",
        "light_chain": "QIVLSQSPAILSASPGEKVTMTCRASSSVSYIHWFQQKPGSSPKPWIYATSNLASGVPVRFSGSGSGTSYSLTISRVEAEDAATYYCQQWTSNPPTFGGGTKLEIK"
      },
      "target": "CD20",
      "approved": true,
      "year": 1997,
      "company": "Biogen/Genentech",
      "disease_areas": ["Non-Hodgkin's Lymphoma", "Chronic Lymphocytic Leukemia"],
      "antibody_type": "Chimeric",
      "isotype": "IgG1",
      "cdr_regions": {
        "heavy": {
          "cdr1": "SYNMH",
          "cdr2": "AIYPGNGDTSYNQKFKG",
          "cdr3": "STYYGGDWYFNV"
        },
        "light": {
          "cdr1": "RASSSVSYIH",
          "cdr2": "ATSNLAS",
          "cdr3": "QQWTSNPPT"
        }
      }
    },
    {
      "name": "Nivolumab",
      "sequence": {
        "heavy_chain": "QVQLVESGGGVVQPGRSLRLSCAASGFTFSRQALMWVRQAPGKGLEWVAVISYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDRGDYYRFAYWGQGTLVTVSS",
        "light_chain": "EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQSSNWPRTFGQGTKVEIK"
      },
      "target": "PD-1",
      "approved": true,
      "year": 2014,
      "company": "Bristol-Myers Squibb",
      "disease_areas": ["Melanoma", "Lung Cancer", "Renal Cell Carcinoma"],
      "antibody_type": "Human",
      "isotype": "IgG4",
      "cdr_regions": {
        "heavy": {
          "cdr1": "GFTFSRQALM",
          "cdr2": "VISYDGSNKYYA",
          "cdr3": "ARDRGDYYRF"
        },
        "light": {
          "cdr1": "RASQSVSSYLA",
          "cdr2": "DASNRAT",
          "cdr3": "QQSSNWPRT"
        }
      }
    }
  ],
  "metadata": {
    "version": "2.0",
    "last_updated": "2025-09-26",
    "total_antibodies": 5,
    "source": "FDA/EMA approved therapeutic antibodies",
    "data_fields": {
      "sequence": "Split into heavy and light chains",
      "cdr_regions": "Based on Kabat numbering scheme",
      "disease_areas": "Primary indications",
      "antibody_type": "Classification based on origin",
      "isotype": "Antibody class"
    },
    "references": [
      "IMGT Antibody Database",
      "DrugBank",
      "FDA Biological Approvals",
      "EMA Medicine Database"
    ]
  },
  "validation_metrics": {
    "sequence_length": {
      "heavy_chain": {
        "min": 110,
        "max": 130,
        "mean": 120
      },
      "light_chain": {
        "min": 105,
        "max": 115,
        "mean": 110
      }
    },
    "cdr_length_ranges": {
      "heavy": {
        "cdr1": [5, 10],
        "cdr2": [12, 17],
        "cdr3": [9, 17]
      },
      "light": {
        "cdr1": [10, 12],
        "cdr2": [7, 8],
        "cdr3": [8, 10]
      }
    },
    "framework_conservation": {
      "heavy": 0.85,
      "light": 0.90
    }
  }
}